✦ LIBER ✦

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

✍ Scribed by Malka, David; Cervera, Pascale; Foulon, Stéphanie; Trarbach, Tanja; de la Fouchardière, Christelle; Boucher, Eveline; Fartoux, Laetitia; Faivre, Sandrine; Blanc, Jean-Frédéric; Viret, Frédéric; Assenat, Eric; Seufferlein, Thomas; Herrmann, Thomas; Grenier, Julien; Hammel, Pascal; Dollinger, Matthias; André, Thierry; Hahn, Philipp; Heinemann, Volker; Rousseau, Vanessa; Ducreux, Michel; Pignon, Jean-Pierre; Wendum, Dominique; Rosmorduc, Olivier; Greten, Tim F

Book ID: 124115286
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 296 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70212-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and oxaliplatin with or with

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

✍ Jeeyun Lee; Se Hoon Park; Heung-Moon Chang; Jun Suk Kim; Hye Jin Choi; Myung Ah 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 221 KB

Cetuximab, gemcitabine, and oxaliplatin

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

✍ Birgit Gruenberger; Johannes Schueller; Ute Heubrandtner; Fritz Wrba; Dietmar Ta 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 180 KB

Capecitabine and cisplatin with or witho

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

✍ Lordick, Florian; Kang, Yoon-Koo; Chung, Hyun-Cheol; Salman, Pamela; Oh, Sang Ch 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 323 KB

Oxaliplatin, fluorouracil, and leucovori

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

✍ Taieb, Julien; Tabernero, Josep; Mini, Enrico; Subtil, Fabien; Folprecht, Gunnar 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 466 KB

Epirubicin, oxaliplatin, and capecitabin

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

✍ Waddell, Tom; Chau, Ian; Cunningham, David; Gonzalez, David; Okines, Alicia Fran 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 396 KB

Docetaxel or pemetrexed with or without

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

✍ Kim, Edward S; Neubauer, Marcus; Cohn, Allen; Schwartzberg, Lee; Garbo, Lawrence 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 283 KB